The Disruptors: Driving I&I Therapy Adoption with Oral Formulations

Grand Ballroom

Wednesday, June 14, 2023

8:30 AM - 9:10 AM

Disruptors

Watch Panel Here

Focus on Inflammation and Immunology has grown massively over the past couple of decades. Initial focus was on the utilization of antibodies to block key inflammatory cytokines. Beyond cytokines, the focus shifted to also include B-cell and complement targets. More recently, the field has evolved to incorporate novel chemistry to provide patients with simple, oral solutions in a world dominated by biologics.

Moderator

Steven Greenberg, MD

Neurologist, BWH;

Professor of Neurology, HMS

Panelists

Natalie Holles

CEO, Third Harmonic Bio

Kevin Judice, PhD

CEO & Founder, DICE Therapeutics

Rosana Kapeller, MD, PhD

CEO, ROME Therapeutics

Andre Turenne

CEO, Matchpoint Therapeutics